Please assess the completion status of the following clinical trial:

Trial Title: The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subjects 18 years of age and older.~2. Subject meets the ICHD (International Classification of Headache Disorders)-3 (2018) diagnostic criteria for Migraine with or without aura.~3. Subject reports 1-6 Migraine attacks per month; other headaches no more than 6 days per month.~4. Subject is willing to and capable of complying with the specified study requirements, provided written Informed Consent, can complete the electronic diaries, and can be contacted by telephone.~Exclusion Criteria:~1. Subject having received Botox treatment in the head region in the prior 3 months.~2. Subject having received supraorbital or occipital nerve blocks in the prior month.~3. Past 6 months of chronic migraine, New Daily Persistent Headache, and chronic tension-type headache per ICHD-3 (2018) diagnostic criteria.~4. Current medication overuse headache.~5. Use of opioid medications in the prior 1 month.~6. Use of barbiturates in the prior 1 month.~7. Subject has \>10 headache days per month~8. Implanted metal/shrapnel or electrical devices in the head (not including dental implants), a cardiac pacemaker or an implanted or wearable defibrillator.~9. Received parenteral infusions for migraine within the previous 2 weeks.~10. Subject has known uncontrolled epilepsy.~11. History of neurosurgical interventions~12. Subject with implanted neurostimulators, surgical clips (above the shoulder line) or any medical pumps.~13. Current drug abuse or alcoholism.~14. Subject is participating in any other clinical study.~15. Skin lesion or inflammation at the region of the stimulating electrodes.~16. Personality or somatoform disorder.~17. Pregnancy or Lactation.~18. Women with child bearing potential without medically acceptable method of contraception (NOTE: Females of child bearing potential must have a negative pregnancy test).~19. Documented history of cerebrovascular event.~20. Subject with recent brain or facial trauma (occurred less than 3 months prior to this study).~21. Subject participated in a previous study with the Relivion device.~22. The subject does not have the basic cognitive and motor skills needed to operate a smartphone.~23. Subject with head circumference smaller than 51 centimeters or head circumference larger than 60 centimeters~24. Subject with other significant pain problem that in the opinion of the investigator may confound the study assessments.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active (Type: ACTIVE_COMPARATOR): Relivion Active device
- Sham (Type: SHAM_COMPARATOR): Relivion Sham device

Based on this trial design, predict the completion outcome and termination type (if applicable).